에크모(ECMO) 장비 시장

Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market to Reach US$463.4 Million by 2032

The global market for Extracorporeal Membrane Oxygenation (ECMO) Machine estimated at US$346.3 Million in the year 2025, is expected to reach US$463.4 Million by 2032, growing at a CAGR of 4.3% over the analysis period 2025-2032. Pumps Component, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$144.1 Million by the end of the analysis period. Growth in the Oxygenator Component segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$93.3 Million While China is Forecast to Grow at 7.8% CAGR

The Extracorporeal Membrane Oxygenation (ECMO) Machine market in the U.S. is estimated at US$93.3 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$101.6 Million by the year 2032 trailing a CAGR of 7.8% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Extracorporeal Membrane Oxygenation (ECMO) Machine Market - Key Trends and Drivers Summarized

How Are Extracorporeal Membrane Oxygenation (ECMO) Machines Revolutionizing Critical Care?

Extracorporeal Membrane Oxygenation (ECMO) machines are transforming critical care by providing life-saving support to patients with severe respiratory or cardiac failure. ECMO is a form of extracorporeal life support (ECLS) that oxygenates a patient's blood outside the body, allowing the heart and lungs to rest and recover. ECMO machines work by drawing blood from the patient's body, removing carbon dioxide, adding oxygen, and then returning the oxygenated blood to the patient. This process offers an essential lifeline for individuals suffering from conditions such as acute respiratory distress syndrome (ARDS), cardiogenic shock, or complications from heart surgery, as well as those waiting for lung or heart transplants.

The rise of ECMO technology has revolutionized the management of patients with life-threatening respiratory and cardiac conditions, especially when conventional treatments, such as mechanical ventilation, fail to improve the patient's condition. ECMO machines are now widely used in neonatal, pediatric, and adult intensive care units (ICUs) as a last resort when other interventions are insufficient. The system’s ability to maintain oxygen delivery and blood circulation for extended periods provides critical time for the heart and lungs to heal, improving survival rates in patients with severe, life-threatening conditions. As advances in ECMO technology continue to evolve, the scope of its use in critical care is expanding, offering hope to patients who would otherwise face poor outcomes.

Why Are ECMO Machines Essential for Treating Severe Respiratory and Cardiac Failure?

ECMO machines are essential in treating patients with severe respiratory and cardiac failure because they provide temporary support to vital organs, allowing for recovery when other medical interventions have been exhausted. In cases of severe respiratory failure, such as ARDS or pneumonia, the lungs may be unable to adequately oxygenate the blood, leading to life-threatening complications. ECMO helps by bypassing the lungs entirely, oxygenating the blood outside the body and returning it to the circulatory system, ensuring that oxygen reaches vital organs while the lungs rest and heal. This is particularly important for patients whose lungs have been damaged by trauma, infection, or prolonged ventilation, where traditional mechanical ventilation may not be sufficient to maintain oxygen levels.

Similarly, ECMO is a critical tool for patients suffering from cardiac failure, such as those recovering from heart surgery, experiencing heart attacks, or in cardiogenic shock. In these cases, ECMO takes over the function of the heart by maintaining blood circulation and oxygen delivery. This allows the heart to recover from stress or damage while preventing complications such as organ failure, which can result from inadequate blood flow. ECMO also serves as a bridge to more permanent solutions like heart or lung transplants, giving critically ill patients the time needed for an organ to become available. With the increasing use of ECMO in emergency settings, such as for patients with severe COVID-19 complications, it has proven to be an invaluable tool in providing life support when other treatments are no longer effective, highlighting its importance in modern critical care.

What Are the Expanding Applications and Innovations in ECMO Technology?

The applications of ECMO technology are expanding rapidly, with innovations in the field pushing its use beyond traditional settings and enhancing its capabilities in treating critically ill patients. Initially used primarily in neonatal and pediatric ICUs, ECMO has become an increasingly common intervention in adult patients suffering from severe respiratory or cardiac failure. Its role in treating adult respiratory conditions gained particular attention during the COVID-19 pandemic, where ECMO was used to support patients with severe respiratory complications caused by the virus. As understanding of the technology grows, ECMO is being applied in a wider variety of clinical scenarios, including trauma patients with severe lung injury, post-cardiac arrest patients requiring resuscitation, and those experiencing complications from major surgeries.

Innovations in ECMO technology are enhancing its safety, efficiency, and accessibility. Recent advancements include the development of portable ECMO devices, which enable the transport of critically ill patients between hospitals or within large healthcare facilities. These portable systems allow patients to receive life-saving treatment while en route to specialized care centers, improving survival rates for patients in need of complex interventions. In addition, improvements in circuit design and materials, such as biocompatible coatings that reduce the risk of blood clotting and inflammation, have made ECMO therapy safer and more effective over longer periods. Advances in artificial lungs and oxygenators, which are central to ECMO’s functionality, are also increasing the efficiency of oxygen exchange, further improving outcomes for patients.

Furthermore, the integration of artificial intelligence (AI) and data analytics into ECMO systems is opening new possibilities for personalized care. AI algorithms can be used to monitor and adjust ECMO parameters in real time, optimizing the therapy for each patient based on their individual condition. This precision can reduce the risks associated with ECMO, such as bleeding or clotting, and improve the overall management of critically ill patients. As research and technology in the field of extracorporeal life support continue to advance, ECMO’s applications are expanding beyond ICUs, potentially becoming a staple in emergency care, trauma management, and even long-term chronic care for patients with heart and lung diseases.

What Factors Are Driving the Growth of the ECMO Market?

The growth of the Extracorporeal Membrane Oxygenation (ECMO) machine market is being driven by several key factors, including the rising incidence of respiratory and cardiac diseases, advancements in ECMO technology, and the increased use of ECMO in critical care settings. One of the primary drivers is the growing prevalence of conditions like ARDS, cardiogenic shock, and heart failure, all of which have high mortality rates and often require advanced life support. The COVID-19 pandemic also brought ECMO into the spotlight, as healthcare systems worldwide saw a surge in patients with severe respiratory failure who required ECMO support when other treatments, such as mechanical ventilation, were insufficient. The success of ECMO in improving survival rates for COVID-19 patients with acute lung failure has led to broader recognition of its value in managing respiratory crises, contributing to increased demand for ECMO machines in ICUs and emergency departments.

Technological advancements are also playing a significant role in the growth of the ECMO market. Innovations in device design, including the development of more compact and portable ECMO machines, have made it easier to transport patients while receiving ECMO support. This has expanded the use of ECMO beyond traditional hospital settings, enabling its application in field hospitals, ambulances, and other emergency care scenarios. In addition, improvements in oxygenator efficiency, pump technology, and biocompatible materials are reducing the risks associated with ECMO therapy, such as blood clotting and infection. These innovations are enhancing patient outcomes and increasing the adoption of ECMO in hospitals worldwide.

Another key factor driving the growth of the ECMO market is the rising awareness of the benefits of ECMO in treating critically ill patients, particularly in regions where the technology was previously underutilized. Increased training and education for healthcare professionals on how to operate ECMO machines and manage patients on ECMO support are leading to more widespread implementation of the technology. Furthermore, as healthcare systems in developing regions improve, there is a growing demand for advanced life support technologies like ECMO, which are seen as essential for managing complex cases of respiratory and cardiac failure. Additionally, favorable reimbursement policies and government support for critical care infrastructure are contributing to the market’s expansion, making ECMO more accessible to hospitals and clinics around the world.

In conclusion, the ECMO machine market is set for substantial growth, driven by the rising prevalence of severe respiratory and cardiac conditions, advancements in ECMO technology, and increased recognition of its life-saving capabilities. As ECMO continues to evolve, its applications in critical care, emergency response, and even long-term care will expand, offering new possibilities for improving patient outcomes in the most severe cases of organ failure. With ongoing innovation and increased investment in healthcare infrastructure, ECMO machines will remain a crucial component of modern critical care, providing hope and life-saving support for patients with life-threatening conditions.

SCOPE OF STUDY:

The report analyzes the Extracorporeal Membrane Oxygenation (ECMO) Machine market by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Pumps Component, Oxygenator Component, Controllers Component, Cannula Component, Other Components); Modality (Veno-Arterial Modality, Veno-Venous Modality, Arterio-Venous Modality); Patient Type (Neonates Patient Type, Pediatric Patient Type, Adult Patient Type); Application (Respiratory Application, Cardiac Application, ECPR Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• B. Braun Melsungen AG
• Eurosets S.R.L.
• Getinge AB
• LivaNova PLC
• Medtronic PLC
• MicroPort Scientific Corporation
• Nipro Corporation
• Origen Biomedical, Inc.
• Spectrum Medical (UK) Limited
• Terumo Corporation
• Xenios AG

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2026 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Incidence of Cardiopulmonary Diseases and Respiratory Failures Driving ECMO Machine Demand
  • Growing Number of ECMO Centers Worldwide Expanding Access to Life-saving Treatment
  • Market Trends Toward Portable and Miniaturized ECMO Systems
  • Future Directions: Integration of AI and Machine Learning in ECMO Monitoring
  • Economic Factors Impacting the Affordability and Insurance Coverage for ECMO Therapy
  • Impact of Telemedicine on Remote ECMO Monitoring and Support
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Extracorporeal Membrane Oxygenation (ECMO) Machine Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • TABLE 2: World Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 3: World Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 4: World 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • TABLE 5: World Recent Past, Current & Future Analysis for Pumps Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 6: World Historic Review for Pumps Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 7: World 13-Year Perspective for Pumps Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 8: World Recent Past, Current & Future Analysis for Oxygenator Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 9: World Historic Review for Oxygenator Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 10: World 13-Year Perspective for Oxygenator Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 11: World Recent Past, Current & Future Analysis for Controllers Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 12: World Historic Review for Controllers Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 13: World 13-Year Perspective for Controllers Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 14: World Recent Past, Current & Future Analysis for Cannula Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 15: World Historic Review for Cannula Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 16: World 13-Year Perspective for Cannula Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 18: World Historic Review for Other Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 19: World 13-Year Perspective for Other Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 20: World Recent Past, Current & Future Analysis for Veno-Arterial Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 21: World Historic Review for Veno-Arterial Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 22: World 13-Year Perspective for Veno-Arterial Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 23: World Recent Past, Current & Future Analysis for Veno-Venous Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 24: World Historic Review for Veno-Venous Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 25: World 13-Year Perspective for Veno-Venous Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 26: World Recent Past, Current & Future Analysis for Arterio-Venous Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 27: World Historic Review for Arterio-Venous Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 28: World 13-Year Perspective for Arterio-Venous Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 29: World Recent Past, Current & Future Analysis for Neonates Patient Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 30: World Historic Review for Neonates Patient Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 31: World 13-Year Perspective for Neonates Patient Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 32: World Recent Past, Current & Future Analysis for Pediatric Patient Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 33: World Historic Review for Pediatric Patient Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 34: World 13-Year Perspective for Pediatric Patient Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 35: World Recent Past, Current & Future Analysis for Adult Patient Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 36: World Historic Review for Adult Patient Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 37: World 13-Year Perspective for Adult Patient Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 38: World Recent Past, Current & Future Analysis for Respiratory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 39: World Historic Review for Respiratory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 40: World 13-Year Perspective for Respiratory Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 41: World Recent Past, Current & Future Analysis for Cardiac Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 42: World Historic Review for Cardiac Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 43: World 13-Year Perspective for Cardiac Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • TABLE 44: World Recent Past, Current & Future Analysis for ECPR Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 45: World Historic Review for ECPR Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 46: World 13-Year Perspective for ECPR Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

• UNITED STATES
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 48: USA Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 49: USA 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 50: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 51: USA Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 52: USA 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 53: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 54: USA Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 55: USA 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 56: USA Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 57: USA Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 58: USA 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 60: Canada Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 61: Canada 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 63: Canada Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 64: Canada 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 66: Canada Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 67: Canada 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 69: Canada Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 70: Canada 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• JAPAN
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 72: Japan Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 73: Japan 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 75: Japan Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 76: Japan 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 78: Japan Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 79: Japan 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 81: Japan Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 82: Japan 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• CHINA
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 83: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 84: China Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 85: China 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 86: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 87: China Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 88: China 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 89: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 90: China Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 91: China 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 92: China Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 93: China Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 94: China 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• EUROPE
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 96: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 97: Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 99: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 100: Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 102: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 103: Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 105: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 106: Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 108: Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 109: Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• FRANCE
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 110: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 111: France Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 112: France 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 113: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 114: France Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 115: France 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 116: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 117: France Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 118: France 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 119: France Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 120: France Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 121: France 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• GERMANY
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 123: Germany Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 124: Germany 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 126: Germany Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 127: Germany 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 129: Germany Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 130: Germany 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 132: Germany Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 133: Germany 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 135: Italy Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 136: Italy 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 138: Italy Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 139: Italy 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 141: Italy Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 142: Italy 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 144: Italy Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 145: Italy 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 146: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 147: UK Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 148: UK 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 149: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 150: UK Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 151: UK 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 152: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 153: UK Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 154: UK 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 155: UK Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 156: UK Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 157: UK 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• SPAIN
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 159: Spain Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 160: Spain 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 162: Spain Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 163: Spain 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 165: Spain Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 166: Spain 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 168: Spain Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 169: Spain 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• RUSSIA
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 171: Russia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 172: Russia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 174: Russia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 175: Russia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 177: Russia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 178: Russia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 180: Russia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 181: Russia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 184: Rest of Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 187: Rest of Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 190: Rest of Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 193: Rest of Europe 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• ASIA-PACIFIC
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 196: Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 199: Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 202: Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 205: Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 208: Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
• AUSTRALIA
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 210: Australia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 211: Australia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 213: Australia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 214: Australia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 216: Australia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 217: Australia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 219: Australia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 220: Australia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
• INDIA
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
  • TABLE 221: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 222: India Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 223: India 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
  • TABLE 224: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 225: India Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 226: India 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 227: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 228: India Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 229: India 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 230: India Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 231: India Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 232: India 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
• SOUTH KOREA
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 234: South Korea Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 235: South Korea 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 237: South Korea Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 238: South Korea 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 240: South Korea Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 241: South Korea 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 243: South Korea Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 244: South Korea 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
• REST OF ASIA-PACIFIC
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
• LATIN AMERICA
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 258: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 259: Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 261: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 262: Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 264: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 265: Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 267: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 268: Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 270: Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 271: Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• ARGENTINA
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 273: Argentina Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 274: Argentina 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 276: Argentina Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 277: Argentina 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 279: Argentina Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 280: Argentina 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 282: Argentina Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 283: Argentina 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• BRAZIL
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 285: Brazil Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 286: Brazil 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 288: Brazil Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 289: Brazil 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 291: Brazil Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 292: Brazil 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 294: Brazil Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 295: Brazil 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• MEXICO
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 297: Mexico Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 298: Mexico 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 300: Mexico Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 301: Mexico 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 303: Mexico Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 304: Mexico 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 306: Mexico Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 307: Mexico 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• REST OF LATIN AMERICA
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 310: Rest of Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 313: Rest of Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 316: Rest of Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 319: Rest of Latin America 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• MIDDLE EAST
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 321: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 322: Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 324: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 325: Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 327: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 328: Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • TABLE 330: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 331: Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 333: Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 334: Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• IRAN
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 336: Iran Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 337: Iran 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 339: Iran Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 340: Iran 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 342: Iran Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 343: Iran 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 345: Iran Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 346: Iran 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• ISRAEL
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 348: Israel Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 349: Israel 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 351: Israel Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 352: Israel 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 354: Israel Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 355: Israel 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 357: Israel Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 358: Israel 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• SAUDI ARABIA
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 361: Saudi Arabia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 364: Saudi Arabia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 367: Saudi Arabia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 370: Saudi Arabia 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• UNITED ARAB EMIRATES
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 372: UAE Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 373: UAE 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 375: UAE Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 376: UAE 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 378: UAE Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 379: UAE 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 381: UAE Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 382: UAE 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• REST OF MIDDLE EAST
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 385: Rest of Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 388: Rest of Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 391: Rest of Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 394: Rest of Middle East 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032
• AFRICA
  • Extracorporeal Membrane Oxygenation (ECMO) Machine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 396: Africa Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Neonates Patient Type, Pediatric Patient Type and Adult Patient Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 397: Africa 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Patient Type - Percentage Breakdown of Value Sales for Neonates Patient Type, Pediatric Patient Type and Adult Patient Type for the Years 2020, 2026 & 2032
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 399: Africa Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 400: Africa 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Modality - Percentage Breakdown of Value Sales for Veno-Arterial Modality, Veno-Venous Modality and Arterio-Venous Modality for the Years 2020, 2026 & 2032
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 402: Africa Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Respiratory Application, Cardiac Application and ECPR Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 403: Africa 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Application - Percentage Breakdown of Value Sales for Respiratory Application, Cardiac Application and ECPR Application for the Years 2020, 2026 & 2032
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • TABLE 405: Africa Historic Review for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • TABLE 406: Africa 13-Year Perspective for Extracorporeal Membrane Oxygenation (ECMO) Machine by Component - Percentage Breakdown of Value Sales for Pumps Component, Oxygenator Component, Controllers Component, Cannula Component and Other Components for the Years 2020, 2026 & 2032

IV. COMPETITION